Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neus Villamor

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Haematologica|June 29, 2014
Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic modelTycho Baumann, Julio Delgado, Rodrigo Santacruz, et al.
British Journal of Haematology|December 11, 2002
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemiaFrancesc Bosch, Anna Ferrer, Armando López-Guillermo, et al.
Experimental Hematology|October 13, 2005
Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantationMónica Jiménez, Carmen Martínez, Guadalupe Ercilla, et al.
Oncotarget|June 13, 2015
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaSílvia Xargay-Torrent, Mónica López-Guerra, Laia Rosich, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocationMaría Rozman, Mireia Camós, Dolors Colomer, et al.
Annals of Hematology|February 25, 2021
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapySilvia Marcé, Olga Balagué, Luis Colomo, et al.
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2016
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor OutcomeJordina Rovira, Kennosuke Karube, Alexandra Valera, et al.
Blood Cancer Journal|March 7, 2020
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experiencePablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Haematologica|June 29, 2014
Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic modelTycho Baumann, Julio Delgado, Rodrigo Santacruz, et al.
British Journal of Haematology|December 11, 2002
Fludarabine, cyclophosphamide and mitoxantrone in the treatment of resistant or relapsed chronic lymphocytic leukaemiaFrancesc Bosch, Anna Ferrer, Armando López-Guillermo, et al.
Experimental Hematology|October 13, 2005
Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantationMónica Jiménez, Carmen Martínez, Guadalupe Ercilla, et al.
Oncotarget|June 13, 2015
The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemiaSílvia Xargay-Torrent, Mónica López-Guerra, Laia Rosich, et al.
Genes, Chromosomes & Cancer|April 22, 2004
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocationMaría Rozman, Mireia Camós, Dolors Colomer, et al.
Annals of Hematology|February 25, 2021
Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaPablo Mozas, Andrea Rivero, Alfredo Rivas-Delgado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapySilvia Marcé, Olga Balagué, Luis Colomo, et al.
Haematologica|April 28, 2010
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behaviorEva Giné, Antoni Martinez, Neus Villamor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2016
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor OutcomeJordina Rovira, Kennosuke Karube, Alexandra Valera, et al.
Blood Cancer Journal|March 7, 2020
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experiencePablo Mozas, Ferran Nadeu, Alfredo Rivas-Delgado, et al.
Pageof 14